Managing Immune Checkpoint-Blocking Antibody Side Effects
Immune checkpoint-blocking antibodies that enhance the immune system's ability to fight cancer are becoming important components of treatment for patients with a variety of malignancies. Cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) was the first immune checkpoint to be clinically target...
Sparad:
| Huvudupphovsman: | |
|---|---|
| Materialtyp: | Revisão |
| Språk: | engelska |
| Publicerad: |
2015
|
| Länkar: | https://doi.org/10.14694/edbook_am.2015.35.76 https://ascopubs.org/doi/pdfdirect/10.14694/EdBook_AM.2015.35.76 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|
Lägg till första kommentaren!